← All trials
NCT00861952
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2010
- Primary completion
- —
- Completion date
- —
- First posted
- Mar 16, 2009
- Last posted
- Mar 17, 2015
- Enrollment
- 0
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- The Canadian College of Naturopathic MedicineLead sponsor
- Dalhousie UniversityStudy chair
- University of AdelaideCollaborator
- The Canadian College of Naturopathic MedicineOverall official - principal investigator
- The Canadian College of Naturopathic MedicineReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.